Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, FDA

4WEB Medical Announces FDA 510(k) Clearance of its Cervical Stand-Alone Interbody Fusion Device


DALLAS, Aug. 28, 2019 /PRNewswire/ -- 4WEB Medical, an orthopedic device company focused on developing innovative implants utilizing its proprietary Truss Implant Technologytm, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Cervical Spine Truss System-Stand Alone (CSTS-SA) Interbody Fusion Device.

Cervical Spine Truss System ? Stand-Alone

Consistent with 4WEB's existing product portfolio, CSTS-SA has an open architecture, Advanced Structural Design that incorporates the company's proprietary Truss Implant Technologytm. The CSTS-SA product is designed to allow fixation screws to be placed through the truss implant and into the adjacent vertebral bodies creating a zero-profile stand-alone construct that removes the need for traditional plate and screw fixation.  Additionally, the device features a single-step locking mechanism that provides surgeon users confidence in the performance of the stand-alone construct. The Cervical Stand-Alone product line will be available in multiple footprints, lordotic angles, heights and will be delivered in sterile packaging for hospital efficiency and patient safety. 4WEB expects to take the product to market at the beginning of the fourth quarter.

"We are thrilled to be able to expand our market leading portfolio in the titanium interbody space. The addition of the Cervical Spine Truss System-Stand Alone product line not only broadens our current portfolio, but represents the first of many products to be released that will provide significant growth for the organization," said Jim Bruty, Sr. Vice President of Sales and Marketing. "4WEB will continue to provide clinicians with disruptive, clinically beneficial technology achieved through product development."

4WEB Medical's proprietary Truss Implant Technologytm utilizes the concept of mechanobiology to simulate cellular activity at the surgical site.  The manufacturing process used to produce the implant's Advanced Structural Design creates a hierarchical surface roughness with features that span from the macro to nano scale.  In-vitro testing has shown that stem cells attached to 4WEB's titanium implant surface exhibited increased gene expression of certain osteogenic markers when compared to smooth titanium and PEEK. 

The company remains focused on accelerating growth over the next 5 years with investments in product development, procedural based solutions and clinical research.

About 4WEB Medical
4WEB Medical is an orthopedic implant device company founded in 2008 in Dallas, Texas. Thirty years of research in topological dimension theory led to the discovery of a novel geometry, the 4WEB, that can be used as a building block to create high-strength, lightweight web structures. The company leveraged this breakthrough along with cutting-edge 3D printing technology to develop 4WEB Medical's proprietary truss implant platform. The 4WEB Medical product portfolio includes Cervical, Anterior, Posterior and Lateral Spine Truss Systems, as well as the Osteotomy Truss System and custom implant services for extremity, tumor and trauma procedures. To learn more about 4WEB Medical's Truss Implant Technologytm visit www.4webmedical.com.

SOURCE 4WEB Medical


These press releases may also interest you

at 22:20
Genial Technology, Inc. is excited to announce the launch of GenialAItm OCR, a SaaS product that will reduce document processing costs while maintaining accuracy and security. The official launch date for GenialAItm OCR is July 9, 2020. As the...

at 21:05
Yamato Holdings Co., Ltd. ("Yamato") and Palantir Technologies Inc. ("Palantir") have announced the beginning of their work to accelerate the digital transformation ("DX") of the logistics industry by transforming Yamato's internal operations. Yamato...

at 21:01
The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least...

at 20:50
Aurora Spine Corporation ("Aurora Spine" or the "Company") announces financial results for the First Quarter 2020, ended March 31, 2020.  All figures are in U.S. dollars. To our Shareholders: Q1 2020 started strongly for the Company based on...

at 19:35
Technavio has been monitoring the artificial intelligence platforms market and it is poised to grow by USD 12.51 billion during 2020-2024, progressing at a CAGR of over 33% during the forecast period. The report offers an up-to-date analysis...

at 19:32
Duvora has introduced an AI-driven video platform dedicated to virtual luxury home tours as a new way to meet the needs of affluent home buyers in a post COVID-19 world....



News published on 28 august 2019 at 13:42 and distributed by: